Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Breast cancer
ADR ID BADD_A00673
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.10      Breast neoplasms malignant and unspecified (incl nipple)
16.10.01      Breast and nipple neoplasms malignant
16.10.01.001      Breast cancer
21      Reproductive system and breast disorders
21.05      Breast disorders
21.05.01      Benign and malignant breast neoplasms
21.05.01.003      Breast cancer
Description Tumors or cancer of the human BREAST. | Cancer of the human MAMMARY GLAND. | Tumor or cancer of the human MAMMARY GLAND. [MeSH]
MedDRA Code 10006187
MeSH ID D001943
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Breast adenocarcinoma | Breast cancer | Breast cancer NOS | Breast cancer stage unspecified | Breast carcinoma | Breast carcinoma NOS | Breast lump (malignant) | Breast tumor malignant | Breast tumour malignant | Ca breast | Carcinoma breast | Malignant breast neoplasm | Breast cancer aggravated | Contralateral breast cancer | Adenoid cystic breast carcinoma | Node-positive breast cancer | Node-negative breast cancer | Advanced breast cancer | Locally advanced breast cancer | Breast Neoplasms | Breast Neoplasm | Neoplasm, Breast | Breast Tumors | Breast Tumor | Tumor, Breast | Tumors, Breast | Neoplasms, Breast | Breast Cancer | Cancer, Breast | Mammary Cancer | Cancer, Mammary | Cancers, Mammary | Mammary Cancers | Malignant Neoplasm of Breast | Breast Malignant Neoplasm | Breast Malignant Neoplasms | Malignant Tumor of Breast | Breast Malignant Tumor | Breast Malignant Tumors | Cancer of Breast | Cancer of the Breast | Mammary Carcinoma, Human | Carcinoma, Human Mammary | Carcinomas, Human Mammary | Human Mammary Carcinomas | Mammary Carcinomas, Human | Human Mammary Carcinoma | Mammary Neoplasms, Human | Human Mammary Neoplasm | Human Mammary Neoplasms | Neoplasm, Human Mammary | Neoplasms, Human Mammary | Mammary Neoplasm, Human | Breast Carcinoma | Breast Carcinomas | Carcinoma, Breast | Carcinomas, Breast
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01020Glatiramer--
BADD_D01021Glatiramer acetate--
BADD_D01038Goserelin0.000501%
BADD_D01054Haloperidol0.000376%
BADD_D01103Hydroxychloroquine0.004648%
BADD_D01110Hydroxyurea0.000616%
BADD_D01213Isotretinoin--
BADD_D01248Lapatinib0.001366%
BADD_D01257Letrozole0.010142%
BADD_D01281Levonorgestrel0.042551%
BADD_D01285Levothyroxine--
BADD_D01298Liraglutide--
BADD_D01330Lurasidone--
BADD_D01365Medroxyprogesterone--
BADD_D01366Medroxyprogesterone acetate--
BADD_D01397Mesalamine0.000549%
BADD_D01418Methotrexate--
BADD_D01475Mirabegron--
BADD_D01480Mitoxantrone0.000112%
BADD_D01506Muromonab-cd3--
BADD_D01507Mycophenolate mofetil--
BADD_D01533Naproxen--
BADD_D01586Norethindrone acetate--
BADD_D01601Olaparib0.000728%
BADD_D01653Paclitaxel0.002753%
BADD_D01662Pamidronic acid--
BADD_D01676Paricalcitol--
BADD_D01679Paroxetine--
BADD_D01735Pergolide--
BADD_D01736Pergolide mesylate--
The 3th Page    First    Pre   3 4 5    Next   Last    Total 5 Pages
ADReCS-Target
ADR Term Drug Name Target